#USA #LabConnect #radiopharmaceuticals #Johnson City, Tennessee #Bracken Group

LabConnect and Bracken Group Join Forces

LabConnect, a prominent provider of global central laboratory and support services for clinical trials, has revealed its strategic partnership with the Bracken Group, aiming to expand its capabilities in the field of radiopharmaceutical support services. This alliance comes at a time when the industry is projected to grow by 15 to 20% annually, highlighting the increasing demand for specialized expertise in radiopharmaceuticals.

The Bracken Group is respected for its scientific leadership and strategic expertise in radiopharmaceuticals. Renowned for its thought leadership and comprehensive scientific approach, Bracken possesses unparalleled knowledge in product development, regulatory approval, and market strategies.

"This partnership presents a unique opportunity to merge operational excellence with in-depth scientific knowledge," stated Wes Wheeler, CEO of LabConnect. He further emphasized that Bracken's expertise will enhance LabConnect's ability to assist global clients in navigating the complex logistical and analytical challenges of radiopharmaceutical studies.

Colin Miller, PhD, the CEO of Bracken Consulting, echoed this sentiment, stating, "LabConnect's commitment to innovation aligns well with Bracken's mission. Together, we are establishing a bridge between medicine, science, and operations that is unmatched in our industry." Bracken is recognized as a leading consultancy in the development of radiopharmaceuticals from preclinical stages to market strategy. By partnering with LabConnect, they aim to expand their expertise further and position LabConnect as the preferred partner for radiopharmaceutical development, catering to both diagnostics and radiolabeled therapy (RLT).

The collaboration will focus on enhancing services in critical areas such as sample processing, logistics, and scientific oversight, which are essential components in the tightly regulated and complex radiopharmaceutical sector. Through this partnership, both companies are committed to improving the quality and efficiency of radiopharmaceutical developments, thus benefiting biopharmaceutical and biotech clients in their pursuit of targeted treatments and diagnostics.

About LabConnect

LabConnect, LLC stands at the forefront of central laboratory services, providing scientific consulting, data integration and transformation services for analytically and logistically complex studies. These studies include immuno-oncology, cell and gene therapies, as well as rare diseases. Its unique combination of cutting-edge technology, premier laboratories, straightforward access to crucial and emerging markets, and extensive experience in specialized testing makes LabConnect a reliable partner in meeting all central laboratory needs for pharmaceutical development companies.

For more information, visit www.labconnect.com and follow them on LinkedIn.

About Bracken

The Bracken Group delivers consulting, regulatory, analytics, marketing, and sales solutions for the life sciences and digital health sectors. With high-caliber advisory and support services, business programs, and data-driven products, Bracken adopts a multidisciplinary approach to exceed its clients' objectives. For more insights, visit www.thebrackengroup.com and follow them on LinkedIn.